Life-threatening Hyperkalemia Associated with Axitinib Treatment in Patients with Recurrent Renal Carcinoma

Axitinib has emerged as a promising antineoplastic agent for the treatment of advanced renal cell carcinoma. Although the administration of axitinib was well-tolerated in clinical trials, the real-world safety and tolerability remain unverified. We herein report a patient with metastatic renal cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Godo, Shigeo, Yoshida, Yoshitaro, Kawamorita, Naoki, Mitsuzuka, Koji, Kawazoe, Yu, Fujita, Motoo, Kudo, Daisuke, Nomura, Ryosuke, Shimokawa, Hiroaki, Kushimoto, Shigeki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207819/
https://www.ncbi.nlm.nih.gov/pubmed/29780111
http://dx.doi.org/10.2169/internalmedicine.0262-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207819/
https://www.ncbi.nlm.nih.gov/pubmed/29780111
http://dx.doi.org/10.2169/internalmedicine.0262-17

Ejemplares similares